VIRTUAL INCISION CORP

Profile

Company Names

VIRTUAL INCISION CORP

Addresses

1501 OLD CHENEY RD, LINCOLN, NE 68512

2125 TRANSFORMATION DRIVE, SUITE 1300, LINCOLN, NE 68508

7021 KOLL CENTER PARKWAY, #105, PLEASANTON, CA 94566

7021 KOLL CENTER PARKWAY, SUITE 103, PLEASANTON, CA 94566

5708 S. REMINGTON PLACE, SUITE 600, SIOUX FALLS, SD 57108

983280 NEBRASKA MEDICAL CENTER, OMAHA, NE 68198

Phone Numbers

925-413-8172
605 - 271 - 8019
402 472 5805

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, OTHER HEALTH CARE

Year Incorporated:

2006

State Incorporated:

DELAWARE

Total Amount Raised:

$100,794,769.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2025-03-20 
$7,949,160.00 
$25,000,000.00 
$17,050,840.00 
Debt 
8
2023-06-22 
$10,971,230.00 
$22,499,999.00 
$11,528,769.00 
Equity 
7
2021-11-29 
$46,557,140.00 
$46,557,140.00 
$0.00 
Equity 
6
2021-09-16 
$4,000,000.00 
$4,000,000.00 
$0.00 
Debt 
5
2019-10-15 
$10,099,921.00 
$25,000,000.00 
$14,900,079.00 
Equity 
4
2019-06-26 
$2,300,000.00 
$3,000,000.00 
$700,000.00 
Debt 
3
2017-12-01 
$15,300,038.00 
$18,300,038.00 
$3,000,000.00 
Equity 
2
2015-06-30 
$1,790,488.00 
$4,400,000.00 
$2,609,512.00 
Equity 
1
2010-10-28 
$1,826,792.00 
$1,826,792.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROB 
 
BARMANN 
DIRECTOR
SHANE 
 
FARRITOR 
EXECUTIVE OFFICER, DIRECTOR
MIKE 
 
JERSTAD 
DIRECTOR
AMY 
 
KOBE 
DIRECTOR
TAO 
 
LIN 
DIRECTOR
JOHN 
P. 
MURPHY 
EXECUTIVE OFFICER, DIRECTOR
DMITRY 
 
OLEYNIKOV 
EXECUTIVE OFFICER, DIRECTOR
FERNANDO 
 
PACHECO 
DIRECTOR
FRED 
 
ROBERTSON 
DIRECTOR
TOM 
 
SHEHAB 
DIRECTOR
SHI 
 
SHENGHAO 
DIRECTOR
MUKUND 
 
SRINIVASAN 
EXECUTIVE OFFICER
LEWEI 
 
WANG 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-03-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-03-20 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-09-16 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2019-06-26 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-01 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-30 
D
OTHER HEALTH CARE 
 
NO REVENUES 
Equity 
2010-10-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#